Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03085875 · ClinicalTrials.gov registry record
POWERMOM, A Healthy Pregnancy Research Community
A clinical trial of Pregnancy Related and Behavior, sponsored by Scripps Translational Science Institute.
- Recruiting
- Registry status
- 100,000
- Enrollment target
- 1
- Study location
NCT03085875: Recruiting study of Pregnancy Related and Behavior, sponsored by Scripps Translational Science Institute.
NCT03085875 is a study of Pregnancy Related and Behavior that is actively recruiting participants, run by Scripps Translational Science Institute. The registered enrollment target is 100,000 participants, above the 953-participant average among 99 other Pregnancy Related trials with a reported enrollment target (10393% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03085875, a study of Pregnancy Related and Behavior, is actively recruiting participants, sponsored by Scripps Translational Science Institute.
- RECRUITING
- Registry status
- 100,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will take advantage of the open source framework of ResearchKit developed by Apple to bring research directly to participants. Using the ResearchKit platform as well as a stand alone app available for Android and HTML, it makes it easier to enroll large numbers of participants and carry out real-world health research to answer questions important to a broad population.
Primary Outcome
Weight (lbs.) will be collected using surveys and measured with home and medical office scales.
Conditions Studied
Study Locations (1)
California
- Scripps Research Translational Institute - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100,000 participants |
| Start Date | 2017-03-16 |
| Est. Completion | 2027-07-31 |
What NCT03085875 shows while recruiting
NCT03085875 is an observational study that tracks outcomes without assigning an intervention. Its 100,000 participants enrollment target places it among the larger protocols in the corpus, above the 953-participant average among 99 other Pregnancy Related trials with a reported enrollment target (10393% higher).
The record links to 4 conditions, with Pregnancy Related appearing as the primary indexed condition, and to 0 interventions.
NCT03085875 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03085875 about?
NCT03085875 is a clinical study titled "POWERMOM, A Healthy Pregnancy Research Community". This study will take advantage of the open source framework of ResearchKit developed by Apple to bring research directly to participants. Using the ResearchKit platform as well as a stand alone app available for Android and HTML, it makes it easier to enroll large numbers of participants and carry o...
What is the current status of trial NCT03085875?
This trial is currently recruiting. The enrollment target is 100,000 participants. The study started on 2017-03-16. Estimated completion is 2027-07-31.
What conditions does trial NCT03085875 study?
This clinical trial studies the following conditions: Pregnancy Related, Behavior, Weight Change, Body, Health Problems in Pregnancy.
Who is sponsoring clinical trial NCT03085875?
This trial is sponsored by Scripps Translational Science Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03085875 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Related
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03085875's enrollment target sits among peer trials
100,000 1st of 99 higher than 99 of 99 other Pregnancy Related trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy Related trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Antenatal Support for Iron Deficiency Anemia
RECRUITING · Phase 4
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
RECRUITING
-
Mobile Application-based Exercise Intervention for Pregnant Women
RECRUITING · NA
-
Rigorous Evaluation of Yes and Know, a Fully Virtual Sexual Health and Well-Being Intervention for Youth
RECRUITING · NA
-
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
RECRUITING
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02620852 · 100,000 participants · NA
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
- NCT03277365 · 100,000 participants · NA
MyGeneRank: A Digital Platform for Next-Generation Genetic Studies
- NCT04281823 · 100,000 participants
DeBakey Cardiovascular Magnetic Resonance Study
- NCT04869111 · 100,000 participants · NA
The BrainHealth Project
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI